Serious Asthma Events with Mometasone Furoate Plus Formoterol Compared With Mometasone Furoate

This global, randomized, double-blind, 26-week trial in 11,729 patients with persistent asthma demonstrated that mometasone furoate-formoterol does not increase serious asthma outcome risk and reduces asthma exacerbation risk compared with mometasone furoate alone.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research